Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Vaccitech Doses First Patient in HBV002 for Chronic HBV

americanpharmaceuticalreviewFebruary 04, 2021

Tag: Vaccitech , HBV002 , HBV , VTP-300

PharmaSources Customer Service